Prudential Financial’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Other funds holding NVCR
SCM
VPM
VCM
QCM
Prudential Financial's NVCR Position: Q1 2026 in Review
Prudential Financial opened a new position in NovoCure (NVCR) in Q1 2026: 15,430 shares worth $168K. The stake represents ﹤0.01% of the portfolio and ranks #2168 among its holdings. This is a return to the name: Prudential Financial previously reported a position in NVCR as recently as Q3 2025.
Prudential Financial first reported a position in NVCR in Q2 2018 and has held it in 17 quarters since. The position peaked at $4.76M in Q2 2019. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.
- Prudential Financial held 15,430 shares of NovoCure worth $168K as of Q1 2026.
- NovoCure was a new Prudential Financial position in Q1 2026.
- NovoCure made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #2168 holding.
- Prudential Financial first reported a position in NovoCure in Q2 2018 and has held it in 17 quarters since.
- Prudential Financial's NovoCure position peaked at $4.76M in Q2 2019.
- 222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.
Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.